Effect of growth hormone on susceptibility to diet-induced obesity

被引:86
作者
Berryman, Darlene E. [1 ]
List, Edward O.
Kohn, Douglas T.
Coschigano, Karen T.
Seeley, Randy J.
Kopchick, John J.
机构
[1] Ohio Univ, Sch Human & Consumer Sci, Grover Ctr W324, Athens, OH 45701 USA
[2] Ohio Univ, Coll Hlth & Human Serv, Edison Biotechnol Inst, Athens, OH 45701 USA
[3] Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA
[4] Univ Cincinnati, Dept Psychiat, Cincinnati, OH 45267 USA
[5] Univ Cincinnati, Genome Res Inst, Cincinnati, OH 45267 USA
关键词
D O I
10.1210/en.2006-0086
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mice with a deficiency in GH function due to disruption of the GH receptor/binding protein gene (GHR(-/-)) are long lived, insulin sensitive, and obese, whereas mice with excess GH function due to expression of a bovine GH transgene (bGH) are short lived, glucose intolerant, and lean. When challenged with a high-fat (HF) diet, we hypothesized that these mice would be differentially susceptible to diet-induced obesity. To test this hypothesis, GHR(-/-), bGH, and littermate control (WT) mice were fed a HF diet (40% kcal) or a nutrient-matched low-fat diet (9% kcal) for 12 wk. On the HF diet, all mice, regardless of genotype, showed a similar percent weight gain and exhibited a significant increase in percent body fat and the mass of epididymal, retroperitoneal, and sc fat pads. For bGH mice, the increase in adipose tissue was relatively small, compared with the WT or GHR(-/-) mice, suggesting some resiliency, although not immunity, to diet-induced obesity. GHR(-/-) mice, which are relatively obese on a low-fat diet, responded to the dietary challenge in a manner similar to WT controls. With HF feeding, all genotypes experienced an increase in insulin levels and depot-dependent effect of adipose tissue. Together, these results further support a role for GH in energy balance regulation and nutrient partitioning. More importantly, because there were genotype-specific effects of diet, these data stress the importance of diet selection and sampling multiple adipose depots in studies with these mouse models.
引用
收藏
页码:2801 / 2808
页数:8
相关论文
共 54 条
[1]   Current and investigational antiobesity agents and obesity therapeutic treatment targets [J].
Bays, HE .
OBESITY RESEARCH, 2004, 12 (08) :1197-1211
[2]   Protection against diabetes-induced nephropathy in growth hormone receptor/binding protein gene-disrupted mice [J].
Bellush, LL ;
Doublier, S ;
Holland, AN ;
Striker, LJ ;
Striker, GE ;
Kopchick, JJ .
ENDOCRINOLOGY, 2000, 141 (01) :163-168
[3]   TREATMENT OF ADULTS WITH GROWTH-HORMONE (GH) DEFICIENCY WITH RECOMBINANT HUMAN GH [J].
BENGTSSON, BA ;
EDEN, S ;
LONN, L ;
KVIST, H ;
STOKLAND, A ;
LINDSTEDT, G ;
BOSAEUS, I ;
TOLLI, J ;
SJOSTROM, L ;
ISAKSSON, OGP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (02) :309-317
[4]   Metabolic actions of growth hormone: Direct and indirect [J].
Berneis, K ;
Keller, U .
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1996, 10 (03) :337-352
[5]   Comparing adiposity profiles in three mouse models with altered GH signaling [J].
Berryman, DE ;
List, EO ;
Coschigano, KT ;
Behar, K ;
Kim, JK ;
Kopchick, JJ .
GROWTH HORMONE & IGF RESEARCH, 2004, 14 (04) :309-318
[6]   ABNORMAL BODY-COMPOSITION AND REDUCED BONE MASS IN GROWTH-HORMONE DEFICIENT HYPOPITUITARY ADULTS [J].
BESHYAH, SA ;
FREEMANTLE, C ;
THOMAS, E ;
RUTHERFORD, O ;
PAGE, B ;
MURPHY, M ;
JOHNSTON, DG .
CLINICAL ENDOCRINOLOGY, 1995, 42 (02) :179-189
[7]   REPLACEMENT TREATMENT WITH BIOSYNTHETIC HUMAN GROWTH-HORMONE IN GROWTH HORMONE-DEFICIENT HYPOPITUITARY ADULTS [J].
BESHYAH, SA ;
FREEMANTLE, C ;
SHAHI, M ;
ANYAOKU, V ;
MERSON, S ;
LYNCH, S ;
SKINNER, E ;
SHARP, P ;
FOALE, R ;
JOHNSTON, DG .
CLINICAL ENDOCRINOLOGY, 1995, 42 (01) :73-84
[8]   Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia [J].
Bohlooly, M ;
Olsson, B ;
Bruder, CEG ;
Lindén, D ;
Sjögren, K ;
Bjursell, M ;
Egecioglu, E ;
Svensson, L ;
Brodin, P ;
Waterton, JC ;
Isaksson, OGP ;
Sundler, F ;
Ahrén, B ;
Ohlsson, C ;
Oscarsson, J ;
Törnell, J .
DIABETES, 2005, 54 (01) :51-62
[9]   Vascular function and blood pressure in GH transgenic mice [J].
Bohlooly-Y, M ;
Carlson, L ;
Olsson, B ;
Gustafsson, H ;
Andersson, IJL ;
Törnell, J ;
Bergström, G .
ENDOCRINOLOGY, 2001, 142 (08) :3317-3323
[10]   EFFECTS OF STREPTOZOTOCIN TREATMENT IN GROWTH-HORMONE (GH) AND GH ANTAGONIST TRANSGENIC MICE [J].
CHEN, NY ;
CHEN, WY ;
BELLUSH, L ;
YANG, CW ;
STRIKER, LJ ;
STRIKER, GE ;
KOPCHICK, JJ .
ENDOCRINOLOGY, 1995, 136 (02) :660-667